Sojournix, a clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative new medicines for the treatment of women’s health and neuroendocrine disorders, announces that Daniel Grau, Chief Executive Officer of Sojournix, will participate in a fireside chat discussing company progress at the Evercore ISI 3rd Annual HealthCONx Virtual Conference on Thursday, December 3 at 3:05pm ET.
November 17, 2020
· 1 min read